Associated Papers
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds.
Alsaihati BA et al.
Nature Communications, 2021
34344882 (PubMed )
Supplement: 41467_2021_24836_MOESM9_ESM.xlsx › CDS_S1_associated_mutations
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_1_early_met_1
Select a paper to view details